Abstract
2003). 13. Miller GJ, Bauer KA, Howarth DJ, Cooper JA, Humphries SE, Rosenberg RD: Increased incidence of neoplasia of the digestive tract in men with persistent activation of the coagulant pathway. J. Thromb. Haemost. 2(12), 2107–2114 (2004). 14. Schulman S, Lindmarker P: Incidence of cancer after prophylaxis with warfarin against recurrent venous thromboembolism. Duration of Anticoagulation Trial. N. Engl. J. Med. 342(26), 1953–1958 (2000). Affiliations • S Nasim Ali, Specialist Registrar in Medical Oncology, Lister Hospital, East & North Hertfordshire NHS Trust, Corey’s Mill Lane, Stevenage, Hertfordshire, UK Tel.: +44 143 878 1416; Fax: +44 143 878 1241; s_nasim_ali@hotmail.com • Justin Stebbing, Senior Lecturer in Medical Oncology Imperial College School of Medicine, Hammersmith Campus, Du Cane Road, London, W12 0NN, UK Tel.: +44 208 383 5828; Fax: +44 208 383 5830; j.stebbing@imperial.ac.uk • Danish Mazhar, MA, PhD, MRCP, Consultant Medical Oncologist Lister Hospital, East & North Hertfordshire NHS Trust, Department of Oncology, Corey’s Mill Lane, Stevenage, Hertfordshire SG1 4AB, UK Tel.: +44 143 878 1416; Fax: +44 143 878 1241; dmazhar@doctors.org.uk
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
